MENU
GRAL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

GRAIL (GRAL) Ownership - Who owns GRAIL?

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection... Show more

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
1.18B
P/E Ratio
N/A
Total Cash
674.58M
Projected Growth
N/A
Total Debt
64.32M
Revenue
130.71M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
18.75
Total Debt/Equity
N/A
Revenue/Share
4.00 USD as % of share price

Fundamentals

GRAL
Capitalization
1.18B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
675M
Total Cash/Share
18.75
Total Debt
64.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.00%
Revenue
131M
ROE
N/A
Book Value
2.41B
P/B Ratio
0.49
Cash Flow
N/A
Earnings
-59.59
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
35K
Current Ratio
9.71
Current Revenue Per Employee
31837.00
Dividends Per Share - Security
N/A
EBITDA
-537.07M
Float
N/A
Float - Current
N/A
Gross Income Margin
-62.60
Revenue To Assets
-50.41
Shares Held By Institutions
984M
Shares Outstanding - Current
36M
Total Liabilities
434M
Total Volume MTD
N/A
Value
N/A
Gain YTD
83.866
View a ticker or compare two or three
GRAL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GRAL showed earnings on May 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details